New radiation therapy aims at Hard-to-Treat prostate cancer
NCT ID NCT06379217
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This early-stage study tests a new type of radiation therapy for men with a rare and aggressive form of prostate cancer that has spread. The treatment uses special scans to find which targets are on the surface of the cancer cells, then delivers a radioactive drug directly to those targets. The goal is to see if this approach is safe and can shrink tumors. About 31 participants will receive up to 6 cycles of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NEUROENDOCRINE PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Memorial Sloan Kettering Cancer Ctr
New York, New York, 10017, United States
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
-
Novartis Investigative Site
Nantes, 44093, France
-
Novartis Investigative Site
München, 80377, Germany
-
Novartis Investigative Site
Rostock, 18057, Germany
-
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Novartis Investigative Site
Madrid, 28041, Spain
-
Novartis Investigative Site
Sutton, Surrey, SM2 5PT, United Kingdom
-
Novartis Investigative Site
London, NW3 2QG, United Kingdom
-
Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
-
Stanford University
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.